ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Combination of Veto Cell Transfer and iNKT Cell Therapy Establishes Complete Hematopoietic Chimerism in Non-Myeloablative BMT Recipients.

R. Ishii,1 T. Hirai,1 Y. Ishii,2 K. Tanabe.1

1Department of Urology, Tokyo Women's Medical University, Tokyo, Japan
2Laboratory for Vaccine Design, RIKEN IMS-RCAI, Yokohama, Japan.

Meeting: 2016 American Transplant Congress

Abstract number: 475

Keywords: Graft-versus-host-disease, Natural killer cells, T cells, Tolerance

Session Information

Date: Tuesday, June 14, 2016

Session Name: Concurrent Session: Bone Marrow Transplantation and Chimerism: Animal Models

Session Time: 4:30pm-6:00pm

 Presentation Time: 4:30pm-4:42pm

Location: Room 313

Related Abstracts
  • T Cell Transfer With iNKT Cell Activation Facilitate Engraftment of Bone Marrow Cells Without GvHD
  • iNKT Cell Activation Under Co-Stimulatory Blockade Establishes Mixed Chimerism Through Thymic Regulatory T Cell Activation.

Hematopoietic chimerism after non-myeloablative bone marrow transplantation (nmBMT) has been found beneficial for establishment of transplant tolerance. Since bone marrow cells (BMCs) are endowed with “veto” activity, reduction in the number of transferred BMCs usually results in engraftment failure in nmBMT. We previously reported that BM engraftment could be promoted by (1) enhancing Treg activity via iNKT cell stimulation with a liposomal α-galactosylceramide (lipo-aGC), and (2) inducing donor-specific peripheral deletion with CD40/CD40L blockade (MR1). Here, we implemented a 3rd strategy: additional transfer of donor-derived T cells as veto cells to facilitate BM engraftment. 3 Gy-irradiated BALB/c (H2d) recipient mice were administered B6 (H2b) BMCs (5 [times] 106) followed by lipo-aGC plus MR1. On the following day, skin grafts from B6 and C3H (H2k) mice were simultaneously transplanted on the recipient mice. When this clinically practical number of BMCs was used, all mice rejected both B6 and C3H grafts. However, when 5 [times] 105 splenic T cells obtained from an H2b+GFP-Tg donor were additionally administered, complete chimerism was established in the mice (fig 1) and they accepted the skin allograft permanently in an H2b-specific manner. Only H2b+CD8+T cells showed this veto effect, whereas transfer of H2b+CD4+T cells or 3rd party T cells did not facilitate BM engraftment. Concordantly, early expansion of GFP+CD44hiCD62Lloeffector CD8+T cells was observed in many lymphoid organs, including the BM and thymus. BM-derived H2b+GFP–T cells immediately regenerated thereafter and had completely replaced GFP+T cells until day 60. Therefore, complete chimeric mice did not show GvHD physically and pathologically. Lack of host reactivity was also confirmed in an in vitro proliferation assay. The mice treated with lipo-aGC or MR1 alone rejected BM and skin grafts despite T cell transfer (fig 2), suggesting that Treg cells, peripheral deletion, and veto T cells act in concert for establishing tolerance in nmBMT recipients.

CITATION INFORMATION: Ishii R, Hirai T, Ishii Y, Tanabe K. Combination of Veto Cell Transfer and iNKT Cell Therapy Establishes Complete Hematopoietic Chimerism in Non-Myeloablative BMT Recipients. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Ishii R, Hirai T, Ishii Y, Tanabe K. Combination of Veto Cell Transfer and iNKT Cell Therapy Establishes Complete Hematopoietic Chimerism in Non-Myeloablative BMT Recipients. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/combination-of-veto-cell-transfer-and-inkt-cell-therapy-establishes-complete-hematopoietic-chimerism-in-non-myeloablative-bmt-recipients/. Accessed February 25, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Left-Sided Donor Nephrectomy Predisposes Living Kidney Donors to Latent Adrenal Insufficiency with Symptoms of Fatigue and Inferior Quality of Life.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.